List With HCPCS Codes For Additional Assorted Quality Measures

The HCPCS codes for Additional Assorted Quality Measures are a set of codes that are used to track and measure various quality measures in healthcare and are described below.

1. HCPCS Code G9188

HCPCS G9188 describes the situation where beta-blocker therapy is not prescribed for a patient, and the reason for not prescribing is not given.

2. HCPCS Code G9189

HCPCS G9189 describes the situation where beta-blocker therapy is prescribed or currently being taken by a patient.

3. HCPCS Code G9190

HCPCS G9190 describes the documentation of medical reasons for not prescribing beta-blocker therapy, such as allergy, intolerance, or other medical reasons.

4. HCPCS Code G9191

HCPCS G9191 describes the documentation of patient reasons for not prescribing beta-blocker therapy, such as patient declined or other patient reasons.

5. HCPCS Code G9212

HCPCS G9212 describes the documentation of DSM-IV criteria for major depressive disorder at the initial evaluation.

6. HCPCS Code G9213

HCPCS G9213 describes the situation where DSM-IV-TR criteria for major depressive disorder are not documented at the initial evaluation, and the reason is not otherwise specified.

7. HCPCS Code G9223

HCPCS G9223 describes the situation where pneumocystis jiroveci pneumonia prophylaxis is prescribed within 3 months of a low CD4+ cell count below 500 cells/mm3 or a CD4 percentage below 15%.

8. HCPCS Code G9225

HCPCS G9225 describes the situation where a foot exam was not performed, and the reason for not performing the exam is not given.

9. HCPCS Code G9226

HCPCS G9226 describes the situation where a foot examination is performed, including visual inspection, sensory exam with a monofilament, and testing of vibration, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam.

10. HCPCS Code G9227

HCPCS G9227 describes the situation where a functional outcome assessment is documented, but a care plan is not documented, or the patient is not eligible for a care plan at the time of the encounter.

11. HCPCS Code G9228

HCPCS G9228 describes the situation where the results of chlamydia, gonorrhea, and syphilis screening are documented.

12. HCPCS Code G9230

HCPCS G9230 describes the situation where chlamydia, gonorrhea, and syphilis screening is not performed, and the reason for not screening is not given.

13. HCPCS Code G9231

HCPCS G9231 describes the documentation of end stage renal disease (ESRD), dialysis, renal transplant, or pregnancy before or during the measurement period.

14. HCPCS Code G9242

HCPCS G9242 describes the documentation of a viral load equal to or greater than 200 copies/ml, or the viral load was not performed.

15. HCPCS Code G9243

HCPCS G9243 describes the documentation of a viral load less than 200 copies/ml.

16. HCPCS Code G9246

HCPCS G9246 describes the situation where a patient did not have at least one medical visit in each 6-month period of the 24-month measurement period, with a minimum of 60 days between medical visits.

17. HCPCS Code G9247

HCPCS G9247 describes the situation where a patient had at least one medical visit in each 6-month period of the 24-month measurement period, with a minimum of 60 days between medical visits.

18. HCPCS Code G9254

HCPCS G9254 describes the documentation of a patient being discharged to home later than post-operative day 2 following carotid artery stenting (CAS).

19. HCPCS Code G9255

HCPCS G9255 describes the documentation of a patient being discharged to home no later than post-operative day 2 following carotid artery stenting (CAS).

20. HCPCS Code G9273

HCPCS G9273 describes the situation where a patient’s blood pressure has a systolic value of less than 140 and a diastolic value of less than 90.

21. HCPCS Code G9412

HCPCS G9412 describes the situation where a patient is admitted within 180 days, status post cardiac implantable electronic device (CIED) implantation, replacement, or revision with an infection requiring device removal or surgical revision.

22. HCPCS Code G9413

HCPCS G9413 describes the situation where a patient is not admitted within 180 days, status post cardiac implantable electronic device (CIED) implantation, replacement, or revision with an infection requiring device removal or surgical revision.

23. HCPCS Code G9414

HCPCS G9414 describes the situation where a patient had one dose of meningococcal vaccine (serogroups A, C, W, Y) on or between the patient’s 11th and 13th birthdays.

24. HCPCS Code G9415

HCPCS G9415 describes the situation where a patient did not have one dose of meningococcal vaccine (serogroups A, C, W, Y) on or between the patient’s 11th and 13th birthdays.

25. HCPCS Code G9416

HCPCS G9416 describes the situation where a patient had one dose of tetanus, diphtheria toxoids and acellular pertussis vaccine (TDAP) on or between the patient’s 10th and 13th birthdays.

26. HCPCS Code G9417

HCPCS G9417 describes the situation where a patient did not have one dose of tetanus, diphtheria toxoids and acellular pertussis vaccine (TDAP) on or between the patient’s 10th and 13th birthdays.

27. HCPCS Code G9418

HCPCS G9418 describes the documentation of a primary non-small cell lung cancer lung biopsy and cytology specimen report that documents classification into a specific histologic type following IASLC guidance or classified as NSCLC-NOS with an explanation.

28. HCPCS Code G9419

HCPCS G9419 describes the documentation of medical reasons for not including the histological type or NSCLC-NOS classification with an explanation, such as insufficient or non-diagnostic specimen, specimen does not contain cancer, or other documented medical reasons.

29. HCPCS Code G9420

HCPCS G9420 describes the situation where the specimen site is other than the anatomic location of the lung or is not classified as primary non-small cell lung cancer.

30. HCPCS Code G9421

HCPCS G9421 describes the documentation of a primary non-small cell lung cancer lung biopsy and cytology specimen report that does not document classification into a specific histologic type or histologic type does not follow IASLC guidance or is classified as NSCLC-NOS without an explanation.

31. HCPCS Code G9422

HCPCS G9422 describes the documentation of a primary lung carcinoma resection report that documents pt category, pn category, and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma and not NSCLC-NOS).

32. HCPCS Code G9423

HCPCS G9423 describes the documentation of medical reasons for not including pt category, pn category, and histologic type for patients with appropriate exclusion criteria (e.g., metastatic disease, benign tumors, malignant tumors other than carcinomas, inadequate surgical specimens).

33. HCPCS Code G9424

HCPCS G9424 describes the situation where the specimen site is other than the anatomic location of the lung, is not classified as non-small cell lung cancer, or is classified as NSCLC-NOS.

34. HCPCS Code G9425

HCPCS G9425 describes the documentation of a primary lung carcinoma resection report that does not document pt category, pn category, and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma).

35. HCPCS Code G9426

HCPCS G9426 describes the improvement in median time from emergency department (ED) arrival to initial ED oral or parenteral pain medication administration performed for ED admitted patients.

36. HCPCS Code G9427

HCPCS G9427 describes the improvement in median time from emergency department (ED) arrival to initial ED oral or parenteral pain medication administration not performed for ED admitted patients.

37. HCPCS Code G9428

HCPCS G9428 describes the pathology report that includes the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status, and presence or absence of microsatellitosis for invasive tumors.

38. HCPCS Code G9429

HCPCS G9429 describes the documentation of medical reasons for not including pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status, and presence or absence of microsatellitosis for invasive tumors, such as negative skin biopsies, insufficient tissue, or other documented medical reasons.

39. HCPCS Code G9430

HCPCS G9430 describes the situation where the specimen site is other than the anatomic cutaneous location.

40. HCPCS Code G9431

HCPCS G9431 describes the pathology report that does not include the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status, and presence or absence of microsatellitosis for invasive tumors.

41. HCPCS Code G9432

HCPCS G9432 describes the assessment of asthma control based on the ACT, C-ACT, ACQ, or ATAQ score, and the results are documented.

42. HCPCS Code G9434

HCPCS G9434 describes the situation where asthma is not well-controlled based on the ACT, C-ACT, ACQ, or ATAQ score, or the specified asthma control tool is not used, and the reason is not given.

43. HCPCS Code G9452

HCPCS G9452 describes the documentation of medical reasons for not receiving HCV antibody test due to limited life expectancy.

44. HCPCS Code G9455

HCPCS G9455 describes the situation where a patient undergoes abdominal imaging with ultrasound, contrast-enhanced CT, or contrast MRI for hepatocellular carcinoma (HCC).

45. HCPCS Code G9456

HCPCS G9456 describes the documentation of medical or patient reasons for not ordering or performing screening for HCC, such as comorbid medical conditions with expected survival less than 5 years, hepatic decompensation and not a candidate for liver transplantation, patient declined, or other patient reasons.

46. HCPCS Code G9457

HCPCS G9457 describes the situation where a patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the submission period.

47. HCPCS Code G9458

HCPCS G9458 describes the documentation of a patient being a tobacco user and receiving tobacco cessation intervention if identified as a tobacco user.

48. HCPCS Code G9459

HCPCS G9459 describes the situation where a patient is currently a tobacco non-user.

49. HCPCS Code G9460

HCPCS G9460 describes the situation where a tobacco assessment or tobacco cessation intervention is not performed, and the reason is not given.

50. HCPCS Code G9468

HCPCS G9468 describes the situation where a patient is not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills.

51. HCPCS Code G9470

HCPCS G9470 describes the situation where patients are not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills.

52. HCPCS Code G9471

HCPCS G9471 describes the situation where central dual-energy X-ray absorptiometry (DXA) is not ordered or documented within the past 2 years.

53. HCPCS Code G9473

HCPCS G9473 describes the services performed by a chaplain in the hospice setting, each 15 minutes.

54. HCPCS Code G9474

HCPCS G9474 describes the services performed by a dietary counselor in the hospice setting, each 15 minutes.

55. HCPCS Code G9475

HCPCS G9475 describes the services performed by another counselor in the hospice setting, each 15 minutes.

56. HCPCS Code G9476

HCPCS G9476 describes the services performed by a volunteer in the hospice setting, each 15 minutes.

57. HCPCS Code G9477

HCPCS G9477 describes the services performed by a care coordinator in the hospice setting, each 15 minutes.

58. HCPCS Code G9478

HCPCS G9478 describes the services performed by another qualified therapist in the hospice setting, each 15 minutes.

59. HCPCS Code G9479

HCPCS G9479 describes the services performed by a qualified pharmacist in the hospice setting, each 15 minutes.

60. HCPCS Code G9480

HCPCS G9480 describes the admission to the Medicare Care Choice Model Program (MCCM).

61. HCPCS Code G9481

HCPCS G9481 describes the remote in-home visit for the evaluation and management of a new patient for use only in a Medicare-approved CMS Innovation Center demonstration project, with specific key components and duration of 10 minutes.

62. HCPCS Code G9482

HCPCS G9482 describes the remote in-home visit for the evaluation and management of a new patient for use only in a Medicare-approved CMS Innovation Center demonstration project, with specific key components and duration of 20 minutes.

63. HCPCS Code G9483

HCPCS G9483 describes the remote in-home visit for the evaluation and management of a new patient for use only in a Medicare-approved CMS Innovation Center demonstration project, with specific key components and duration of 30 minutes.

64. HCPCS Code G9484

HCPCS G9484 describes the remote in-home visit for the evaluation and management of a new patient for use only in a Medicare-approved CMS Innovation Center demonstration project, with specific key components and duration of 45 minutes.

65. HCPCS Code G9485

HCPCS G9485 describes the remote in-home visit for the evaluation and management of a new patient for use only in a Medicare-approved CMS Innovation Center demonstration project, with specific key components and duration of 60 minutes.

66. HCPCS Code G9486

HCPCS G9486 describes the remote in-home visit for the evaluation and management of an established patient for use only in a Medicare-approved CMS Innovation Center demonstration project, with specific key components and duration of 10 minutes.

67. HCPCS Code G9487

HCPCS G9487 describes the remote in-home visit for the evaluation and management of an established patient for use only in a Medicare-approved CMS Innovation Center demonstration project, with specific key components and duration of 15 minutes.

68. HCPCS Code G9488

HCPCS G9488 describes the remote in-home visit for the evaluation and management of an established patient for use only in a Medicare-approved CMS Innovation Center demonstration project, with specific key components and duration of 25 minutes.

69. HCPCS Code G9489

HCPCS G9489 describes the remote in-home visit for the evaluation and management of an established patient for use only in a Medicare-approved CMS Innovation Center demonstration project, with specific key components and duration of 40 minutes.

70. HCPCS Code G9490

HCPCS G9490 describes the CMS Innovation Center models, home visit for patient assessment performed by clinical staff for an individual not considered homebound, including various assessments and services.

71. HCPCS Code G9497

HCPCS G9497 describes the situation where a patient received instruction from the anesthesiologist or proxy prior to the day of surgery to abstain from smoking on the day of surgery.

72. HCPCS Code G9498

HCPCS G9498 describes the situation where an antibiotic regimen is prescribed.

73. HCPCS Code G9500

HCPCS G9500 describes the documentation of radiation exposure indices in the final report for a procedure using fluoroscopy.

74. HCPCS Code G9501

HCPCS G9501 describes the situation where radiation exposure indices are not documented in the final report for a procedure using fluoroscopy, and the reason is not given.

75. HCPCS Code G9502

HCPCS G9502 describes the documentation of a medical reason for not performing a foot exam in patients who have had a bilateral amputation above or below the knee.

76. HCPCS Code G9504

HCPCS G9504 describes the documented reason for not assessing hepatitis B virus (HBV) status prior to initiating anti-TNF therapy.

77. HCPCS Code G9505

HCPCS G9505 describes the antibiotic regimen prescribed within 10 days after the onset of symptoms for a documented medical reason.

78. HCPCS Code G9507

HCPCS G9507 describes the documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications.

79. HCPCS Code G9508

HCPCS G9508 describes the documentation that the patient is not on a statin medication.

80. HCPCS Code G9509

HCPCS G9509 describes adult patients with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month phq-9 or phq-9m score of less than 5.

81. HCPCS Code G9510

HCPCS G9510 describes adult patients with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month phq-9 or phq-9m score of less than 5.

82. HCPCS Code G9511

HCPCS G9511 describes the index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period.

83. HCPCS Code G9512

HCPCS G9512 describes individuals who had a proportion of days covered (PDC) of 0.8 or greater.

84. HCPCS Code G9513

HCPCS G9513 describes individuals who did not have a proportion of days covered (PDC) of 0.8 or greater.

85. HCPCS Code G9514

HCPCS G9514 describes patients who required a return to the operating room within 90 days of surgery.

86. HCPCS Code G9515

HCPCS G9515 describes patients who did not require a return to the operating room within 90 days of surgery.

87. HCPCS Code G9516

HCPCS G9516 describes patients who achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery.

88. HCPCS Code G9517

HCPCS G9517 describes patients who did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given.

89. HCPCS Code G9518

HCPCS G9518 describes the documentation of active injection drug use.

90. HCPCS Code G9519

HCPCS G9519 describes patients who achieve final refraction (spherical equivalent) within 1.0 diopters of their planned refraction within 90 days of surgery.

91. HCPCS Code G9520

HCPCS G9520 describes patients who do not achieve final refraction (spherical equivalent) within 1.0 diopters of their planned refraction within 90 days of surgery.

92. HCPCS Code G9521

HCPCS G9521 describes the total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months.

93. HCPCS Code G9522

HCPCS G9522 describes the total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given.

94. HCPCS Code G9529

HCPCS G9529 describes patients with minor blunt head trauma who had an appropriate indication(s) for a head CT.

95. HCPCS Code G9530

HCPCS G9530 describes patients who presented with minor blunt head trauma and had a head CT ordered for trauma by an emergency care provider.

96. HCPCS Code G9531

HCPCS G9531 describes patients who have documentation of ventricular shunt, brain tumor, multisystem trauma, or are currently taking an antiplatelet medication.

97. HCPCS Code G9533

HCPCS G9533 describes patients with minor blunt head trauma who did not have an appropriate indication(s) for a head CT.

98. HCPCS Code G9537

HCPCS G9537 describes imaging needed as part of a clinical trial or other clinician ordered the study.

99. HCPCS Code G9539

HCPCS G9539 describes the intent for potential removal at the time of placement.

100. HCPCS Code G9540

HCPCS G9540 describes patients who are alive 3 months post procedure.

101. HCPCS Code G9541

HCPCS G9541 describes filters that were removed within 3 months of placement.

102. HCPCS Code G9542

HCPCS G9542 describes the documented re-assessment for the appropriateness of filter removal within 3 months of placement.

103. HCPCS Code G9543

HCPCS G9543 describes the documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement.

104. HCPCS Code G9544

HCPCS G9544 describes patients who do not have the filter removed, documented re-assessment for the appropriateness of filter removal, or documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement.

105. HCPCS Code G9547

HCPCS G9547 describes cystic renal lesions that are simple appearing or adrenal lesions classified as likely benign by imaging protocols.

106. HCPCS Code G9548

HCPCS G9548 describes final reports for imaging studies stating no follow-up imaging is recommended.

107. HCPCS Code G9549

HCPCS G9549 describes the documentation of medical reason(s) that follow-up imaging is indicated.

108. HCPCS Code G9550

HCPCS G9550 describes final reports for imaging studies with follow-up imaging recommended or final reports that do not include a specific recommendation of no follow-up.

109. HCPCS Code G9551

HCPCS G9551 describes final reports for imaging studies without an incidentally found lesion noted.

110. HCPCS Code G9552

HCPCS G9552 describes incidental thyroid nodules less than 1.0 cm noted in reports.

111. HCPCS Code G9553

HCPCS G9553 describes prior thyroid disease diagnosis.

112. HCPCS Code G9554

HCPCS G9554 describes final reports for imaging studies with follow-up imaging recommended.

113. HCPCS Code G9555

HCPCS G9555 describes the documentation of medical reason(s) for recommending follow-up imaging.

114. HCPCS Code G9556

HCPCS G9556 describes final reports for imaging studies with follow-up imaging not recommended.

115. HCPCS Code G9557

HCPCS G9557 describes final reports for imaging studies without an incidentally found thyroid nodule less than 1.0 cm noted or no nodule found.

116. HCPCS Code G9580

HCPCS G9580 describes the door to puncture time of 90 minutes or less.

117. HCPCS Code G9582

HCPCS G9582 describes the door to puncture time of greater than 90 minutes, no reason given.

118. HCPCS Code G9593

HCPCS G9593 describes pediatric patients with minor blunt head trauma classified as low risk according to the pecarn prediction rules.

119. HCPCS Code G9594

HCPCS G9594 describes patients who presented with minor blunt head trauma and had a head CT ordered for trauma by an emergency care provider.

120. HCPCS Code G9595

HCPCS G9595 describes patients who have documentation of ventricular shunt, brain tumor, or coagulopathy.

121. HCPCS Code G9274

HCPCS G9274 describes blood pressure values that indicate hypertension.

122. HCPCS Code G9275

HCPCS G9275 describes the documentation that the patient is a current non-tobacco user.

123. HCPCS Code G9276

HCPCS G9276 describes the documentation that the patient is a current tobacco user.

124. HCPCS Code G9277

HCPCS G9277 describes the documentation that the patient is on daily aspirin or anti-platelet medication or has documentation of a valid contraindication or exception to aspirin/anti-platelet.

125. HCPCS Code G9278

HCPCS G9278 describes the documentation that the patient is not on a daily aspirin or anti-platelet regimen.

126. HCPCS Code G9279

HCPCS G9279 describes the pneumococcal screening performed and documentation of vaccination received prior to discharge.

127. HCPCS Code G9280

HCPCS G9280 describes the pneumococcal vaccination not administered prior to discharge, reason not specified.

128. HCPCS Code G9281

HCPCS G9281 describes the screening performed and documentation that vaccination is not indicated or patient refusal.

129. HCPCS Code G9282

HCPCS G9282 describes the documentation of medical reason(s) for not reporting the histological type or NSCLC-NOS classification with an explanation.

130. HCPCS Code G9283

HCPCS G9283 describes non-small cell lung cancer biopsy and cytology specimen report that documents classification into specific histologic type or classified as NSCLC-NOS with an explanation.

131. HCPCS Code G9597

HCPCS G9597 describes pediatric patients with minor blunt head trauma not classified as low risk according to the pecarn prediction rules.

132. HCPCS Code G9598

HCPCS G9598 describes aortic aneurysm with a maximum diameter of 5.5 – 5.9 cm on imaging studies.

133. HCPCS Code G9599

HCPCS G9599 describes aortic aneurysm with a maximum diameter of 6.0 cm or greater on imaging studies.

134. HCPCS Code G9603

HCPCS G9603 describes patients whose survey score improved from baseline following treatment.

135. HCPCS Code G9604

HCPCS G9604 describes patients whose survey results are not available.

136. HCPCS Code G9605

HCPCS G9605 describes patients whose survey score did not improve from baseline following treatment.

137. HCPCS Code G9606

HCPCS G9606 describes the intraoperative cystoscopy performed to evaluate for lower tract injury.

138. HCPCS Code G9607

HCPCS G9607 describes the documented medical reasons for not performing intraoperative cystoscopy.

139. HCPCS Code G9608

HCPCS G9608 describes the intraoperative cystoscopy not performed to evaluate for lower tract injury.

140. HCPCS Code G9609

HCPCS G9609 describes the documentation of an order for anti-platelet agents.

141. HCPCS Code G9610

HCPCS G9610 describes the documentation of medical reason(s) in the patient’s record for not ordering anti-platelet agents.

142. HCPCS Code G9611

HCPCS G9611 describes the order for anti-platelet agents that was not documented in the patient’s record, reason not given.

143. HCPCS Code G9621

HCPCS G9621 describes patients identified as unhealthy alcohol users when screened for unhealthy alcohol use using a systematic screening method and received brief counseling.

144. HCPCS Code G9622

HCPCS G9622 describes patients not identified as unhealthy alcohol users when screened for unhealthy alcohol use using a systematic screening method.

145. HCPCS Code G9624

HCPCS G9624 describes patients not screened for unhealthy alcohol use using a systematic screening method or patients who did not receive brief counseling if identified as unhealthy alcohol users.

146. HCPCS Code G9625

HCPCS G9625 describes patients who sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery.

147. HCPCS Code G9626

HCPCS G9626 describes the documented medical reasons for not reporting bladder injury.

148. HCPCS Code G9627

HCPCS G9627 describes patients who did not sustain bladder injury at the time of surgery nor discovered subsequently up to 30 days post-surgery.

149. HCPCS Code G9628

HCPCS G9628 describes patients who sustained bowel injury at the time of surgery or discovered subsequently up to 30 days post-surgery.

150. HCPCS Code G9629

HCPCS G9629 describes the documented medical reasons for not reporting bowel injury.

151. HCPCS Code G9630

HCPCS G9630 describes that the patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery.

152. HCPCS Code G9637

HCPCS G9637 describes that the final reports include documentation of one or more dose reduction techniques, such as automated exposure control or adjustment of the ma and/or kv according to patient size.

153. HCPCS Code G9638

HCPCS G9638 describes that the final reports do not include documentation of one or more dose reduction techniques, such as automated exposure control or adjustment of the ma and/or kv according to patient size.

154. HCPCS Code G9642

HCPCS G9642 describes that the patient is a current smoker, using substances such as cigarettes, cigars, pipes, e-cigarettes, or marijuana.

155. HCPCS Code G9643

HCPCS G9643 describes that the surgery performed on the patient was elective, meaning it was planned and not an emergency procedure.

156. HCPCS Code G9644

HCPCS G9644 describes that the patient abstained from smoking prior to anesthesia on the day of surgery or procedure.

157. HCPCS Code G9645

HCPCS G9645 describes that the patient did not abstain from smoking prior to anesthesia on the day of surgery or procedure.

158. HCPCS Code G9646

HCPCS G9646 describes that the patient has a 90-day Modified Rankin Scale (MRS) score of 0 to 2, indicating a low level of disability after a stroke.

159. HCPCS Code G9648

HCPCS G9648 describes that the patient has a 90-day Modified Rankin Scale (MRS) score greater than 2, indicating a higher level of disability after a stroke.

160. HCPCS Code G9649

HCPCS G9649 describes that the psoriasis assessment tool documented meeting any one of the specified benchmarks, such as the Physician Global Assessment (PGA) or Psoriasis Area and Severity Index (PASI).

161. HCPCS Code G9651

HCPCS G9651 describes that the psoriasis assessment tool documented not meeting any one of the specified benchmarks, such as the Physician Global Assessment (PGA) or Psoriasis Area and Severity Index (PASI), or the assessment tool was not documented at all.

162. HCPCS Code G9654

HCPCS G9654 describes that the patient received monitored anesthesia care (MAC), which involves the continuous monitoring and management of a patient’s vital signs during a procedure.

163. HCPCS Code G9655

HCPCS G9655 describes that a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used when transferring a patient directly from the anesthetizing location to a Post-Anesthesia Care Unit (PASU) or other non-ICU location.

164. HCPCS Code G9656

HCPCS G9656 describes that a patient is transferred directly from the anesthetizing location to a Post-Anesthesia Care Unit (PASU) or other non-ICU location.

165. HCPCS Code G9658

HCPCS G9658 describes that a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used when transferring a patient from one location to another.

166. HCPCS Code G9659

HCPCS G9659 describes that patients who are 86 years of age or older and underwent a screening colonoscopy without a history of colorectal cancer or other valid medical reasons for the procedure.

167. HCPCS Code G9660

HCPCS G9660 describes the documentation of medical reasons for performing a colonoscopy on a patient who is 86 years of age or older, such as iron deficiency anemia or changes in bowel habits.

168. HCPCS Code G9661

HCPCS G9661 describes that patients who are 86 years of age or older received a colonoscopy for the assessment of signs/symptoms of gastrointestinal tract illness, high-risk criteria, or follow-up on previously diagnosed advanced lesions.

169. HCPCS Code G9662

HCPCS G9662 describes that the patient has a previous diagnosis or a current diagnosis of clinical atherosclerotic cardiovascular disease (ASCVD), including any ASCVD procedure.

170. HCPCS Code G9663

HCPCS G9663 describes that the patient has an LDL-C (low-density lipoprotein cholesterol) laboratory result equal to or greater than 190 mg/dL, indicating high cholesterol levels.

171. HCPCS Code G9664

HCPCS G9664 describes that the patient is currently using statin therapy or has received a prescription for statin therapy, which is a medication used to lower cholesterol levels.

172. HCPCS Code G9665

HCPCS G9665 describes that the patient is not currently using statin therapy or did not receive a prescription for statin therapy.

173. HCPCS Code G9674

HCPCS G9674 describes that the patient has a clinical diagnosis of atherosclerotic cardiovascular disease (ASCVD), which refers to the buildup of plaque in the arteries.

174. HCPCS Code G9675

HCPCS G9675 describes that the patient has ever had a fasting or direct laboratory result of LDL-C (low-density lipoprotein cholesterol) equal to or greater than 190 mg/dL, indicating high cholesterol levels.

175. HCPCS Code G9676

HCPCS G9676 describes that the patient is between the ages of 40 and 75 and has type 1 or type 2 diabetes, with an LDL-C (low-density lipoprotein cholesterol) result of 70-189 mg/dL recorded as the highest fasting or direct laboratory test result.

176. HCPCS Code G9679

HCPCS G9679 describes that this code is for the onsite acute care treatment of a nursing facility resident with pneumonia and may only be billed once per day per beneficiary.

177. HCPCS Code G9680

HCPCS G9680 describes that this code is for the onsite acute care treatment of a nursing facility resident with congestive heart failure (CHF) and may only be billed once per day per beneficiary.

178. HCPCS Code G9681

HCPCS G9681 describes that this code is for the onsite acute care treatment of a resident with chronic obstructive pulmonary disease (COPD) or asthma and may only be billed once per day per beneficiary.

179. HCPCS Code G9682

HCPCS G9682 describes that this code is for the onsite acute care treatment of a nursing facility resident with a skin infection and may only be billed once per day per beneficiary.

180. HCPCS Code G9683

HCPCS G9683 describes that this code is for facility services for the onsite acute care treatment of a nursing facility resident with a fluid or electrolyte disorder and may only be billed once per day per beneficiary. This service is for a demonstration project.

181. HCPCS Code G9684

HCPCS G9684 describes that this code is for the onsite acute care treatment of a nursing facility resident for a urinary tract infection (UTI) and may only be billed once per day per beneficiary.

182. HCPCS Code G9685

HCPCS G9685 describes that this code is for physician services or other qualified health care professional for the evaluation and management of a beneficiary’s acute change in condition in a nursing facility. This service is for a demonstration project.

183. HCPCS Code G9687

HCPCS G9687 describes that hospice services were provided to the patient at any time during the measurement period.

184. HCPCS Code G9688

HCPCS G9688 describes that the patient used hospice services at any time during the measurement period.

185. HCPCS Code G9689

HCPCS G9689 describes that the patient was admitted for the performance of elective carotid intervention, which refers to a procedure to treat carotid artery disease.

186. HCPCS Code G9690

HCPCS G9690 describes that the patient received hospice services at any time during the measurement period.

187. HCPCS Code G9691

HCPCS G9691 describes that the patient had hospice services at any time during the measurement period.

188. HCPCS Code G9692

HCPCS G9692 describes that hospice services were received by the patient at any time during the measurement period.

189. HCPCS Code G9693

HCPCS G9693 describes that the patient used hospice services at any time during the measurement period.

190. HCPCS Code G9694

HCPCS G9694 describes that hospice services were utilized by the patient at any time during the measurement period.

191. HCPCS Code G9695

HCPCS G9695 describes that a long-acting inhaled bronchodilator was prescribed to the patient.

192. HCPCS Code G9696

HCPCS G9696 describes the documentation of medical reasons for not prescribing a long-acting inhaled bronchodilator, such as patient intolerance or history of side effects.

193. HCPCS Code G9698

HCPCS G9698 describes the documentation of system reasons for not prescribing a long-acting inhaled bronchodilator, such as the cost of treatment or lack of insurance coverage.

194. HCPCS Code G9699

HCPCS G9699 describes that a long-acting inhaled bronchodilator was not prescribed, and the reason is not otherwise specified.

195. HCPCS Code G9700

HCPCS G9700 describes that the patient used hospice services at any time during the measurement period.

196. HCPCS Code G9702

HCPCS G9702 describes that the patient used hospice services at any time during the measurement period.

197. HCPCS Code G9703

HCPCS G9703 describes episodes where the patient is taking antibiotics in the 30 days prior to the episode date.

198. HCPCS Code G9704

HCPCS G9704 describes AJCC breast cancer stage I, specifically T1 mic or T1a documented.

199. HCPCS Code G9705

HCPCS G9705 describes AJCC breast cancer stage I, specifically T1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented.

200. HCPCS Code G9706

HCPCS G9706 describes that the patient has a low (or very low) risk of recurrence of prostate cancer.

201. HCPCS Code G9707

HCPCS G9707 describes that the patient received hospice services at any time during the measurement period.

202. HCPCS Code G9708

HCPCS G9708 describes that women who had a bilateral mastectomy or have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy.

203. HCPCS Code G9709

HCPCS G9709 describes that hospice services were used by the patient at any time during the measurement period.

204. HCPCS Code G9710

HCPCS G9710 describes that the patient was provided hospice services at any time during the measurement period.

205. HCPCS Code G9711

HCPCS G9711 describes patients with a diagnosis or past history of total colectomy or colorectal cancer.

206. HCPCS Code G9712

HCPCS G9712 describes the documentation of medical reasons for prescribing or dispensing an antibiotic, such as intestinal infection or bacterial infection.

207. HCPCS Code G9713

HCPCS G9713 describes that patients used hospice services at any time during the measurement period.

208. HCPCS Code G9714

HCPCS G9714 describes that the patient is using hospice services at any time during the measurement period.

209. HCPCS Code G9716

HCPCS G9716 describes that the patient’s BMI (Body Mass Index) is documented as being outside of normal parameters, and a follow-up plan is not completed for a documented medical reason.

210. HCPCS Code G9717

HCPCS G9717 describes the documentation stating that the patient has had a diagnosis of bipolar disorder.

211. HCPCS Code G9719

HCPCS G9719 describes that the patient is not ambulatory, bedridden, immobile, confined to a chair, wheelchair-bound, dependent on helper pushing wheelchair, independent in a wheelchair, or requires minimal help in a wheelchair.

212. HCPCS Code G9720

HCPCS G9720 describes that hospice services for the patient occurred at any time during the measurement period.

213. HCPCS Code G9721

HCPCS G9721 describes that the patient is not ambulatory, bedridden, immobile, confined to a chair, wheelchair-bound, dependent on helper pushing wheelchair, independent in a wheelchair, or requires minimal help in a wheelchair.

214. HCPCS Code G9722

HCPCS G9722 describes that the patient has a documented history of renal failure or a baseline serum creatinine level equal to or greater than 4.0 mg/dL.

215. HCPCS Code G9723

HCPCS G9723 describes that hospice services for the patient were received at any time during the measurement period.

216. HCPCS Code G9724

HCPCS G9724 describes that patients had documentation of the use of anticoagulant medications overlapping the measurement year.

217. HCPCS Code G9726

HCPCS G9726 describes that the patient refused to participate in the specified activity or treatment.

218. HCPCS Code G9727

HCPCS G9727 describes that the patient was unable to complete the LE-PROM (Lower Extremity Patient-Reported Outcome Measure) at the initial evaluation and/or discharge due to factors such as blindness, illiteracy, severe mental incapacity, or language incompatibility, and an adequate proxy is not available.

219. HCPCS Code G9728

HCPCS G9728 describes that the patient refused to participate in the specified activity or treatment.

220. HCPCS Code G9729

HCPCS G9729 describes that the patient was unable to complete the LE-PROM (Lower Extremity Patient-Reported Outcome Measure) at the initial evaluation and/or discharge due to factors such as blindness, illiteracy, severe mental incapacity, or language incompatibility, and an adequate proxy is not available.

221. HCPCS Code G9284

HCPCS G9284 describes that the non-small cell lung cancer biopsy and cytology specimen report does not document classification into a specific histologic type or is classified as NSCLC-NOS (Non-Small Cell Lung Cancer – Not Otherwise Specified) with an explanation.

222. HCPCS Code G9285

HCPCS G9285 describes that the specimen site is other than the anatomic location of the lung or is not classified as non-small cell lung cancer.

223. HCPCS Code G9286

HCPCS G9286 describes that an antibiotic regimen was prescribed within 10 days after the onset of symptoms.

224. HCPCS Code G9287

HCPCS G9287 describes that an antibiotic regimen was not prescribed within 10 days after the onset of symptoms.

225. HCPCS Code G9288

HCPCS G9288 describes the documentation of medical reasons for not reporting the histological type or NSCLC-NOS classification with an explanation, such as a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons.

226. HCPCS Code G9289

HCPCS G9289 describes that the non-small cell lung cancer biopsy and cytology specimen report documents classification into a specific histologic type or is classified as NSCLC-NOS with an explanation.

227. HCPCS Code G9290

HCPCS G9290 describes that the non-small cell lung cancer biopsy and cytology specimen report does not document classification into a specific histologic type or is classified as NSCLC-NOS with an explanation.

228. HCPCS Code G9291

HCPCS G9291 describes that the specimen site is other than the anatomic location of the lung, is not classified as non-small cell lung cancer, or is classified as NSCLC-NOS.

229. HCPCS Code G9292

HCPCS G9292 describes the documentation of medical reasons for not reporting the PT category and a statement on thickness and ulceration, and for PT1, mitotic rate, such as negative skin biopsies in a patient with a history of melanoma or other documented medical reasons.

230. HCPCS Code G9293

HCPCS G9293 describes that the pathology report does not include the PT category and a statement on thickness and ulceration, and for PT1, mitotic rate.

231. HCPCS Code G9744

HCPCS G9744 describes that the patient is not eligible for the specified activity or treatment due to an active diagnosis of hypertension.

232. HCPCS Code G9745

HCPCS G9745 describes the documented reason for not screening or recommending a follow-up for high blood pressure.

233. HCPCS Code G9746

HCPCS G9746 describes that the patient has mitral stenosis or prosthetic heart valves or has a transient or reversible cause of atrial fibrillation (AF).

234. HCPCS Code G9751

HCPCS G9751 describes that the patient died at any time during the 24-month measurement period.

235. HCPCS Code G9752

HCPCS G9752 describes that the surgery performed on the patient was an emergency procedure.

236. HCPCS Code G9753

HCPCS G9753 describes the documentation of medical reasons for not conducting a search for DICOM format images for prior patient CT imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive, such as emergency cases or situations where time is of the essence.

237. HCPCS Code G9754

HCPCS G9754 describes a finding of an incidental pulmonary nodule, which refers to the discovery of an abnormal growth in the lung that was not the primary focus of the imaging study.

238. HCPCS Code G9755

HCPCS G9755 describes the documentation of medical reasons for not including a recommended interval and modality for follow-up or for no follow-up, and the source of recommendations, such as patients with unexplained fever or immunocompromised patients who are at risk for infection.

239. HCPCS Code G9756

HCPCS G9756 describes surgical procedures that included the use of silicone oil, which is a substance used in certain eye surgeries to help maintain retinal attachment.

240. HCPCS Code G9757

HCPCS G9757 describes surgical procedures that included the use of silicone oil, which is a substance used in certain eye surgeries to help maintain retinal attachment.

241. HCPCS Code G9758

HCPCS G9758 describes that the patient is in hospice at any time during the measurement period.

242. HCPCS Code G9760

HCPCS G9760 describes that patients used hospice services at any time during the measurement period.

243. HCPCS Code G9761

HCPCS G9761 describes that patients used hospice services at any time during the measurement period.

244. HCPCS Code G9762

HCPCS G9762 describes that the patient had at least two HPV vaccines (with at least 146 days between the two) or three HPV vaccines on or between the patient’s 9th and 13th birthdays.

245. HCPCS Code G9763

HCPCS G9763 describes that the patient did not have at least two HPV vaccines (with at least 146 days between the two) or three HPV vaccines on or between the patient’s 9th and 13th birthdays.

246. HCPCS Code G9764

HCPCS G9764 describes that the patient has been treated with a systemic medication for psoriasis vulgaris, a chronic skin condition characterized by red, itchy, and scaly patches.

247. HCPCS Code G9765

HCPCS G9765 describes the documentation that the patient declined a change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months in order to achieve better disease control as measured by the Physician Global Assessment (PGA), Body Surface Area (BSA), Psoriasis Area and Severity Index (PASI), or Dermatology Life Quality Index (DLQI).

248. HCPCS Code G9766

HCPCS G9766 describes that patients are transferred from one institution to another with a known diagnosis of cerebrovascular accident (CVA) for endovascular stroke treatment.

249. HCPCS Code G9767

HCPCS G9767 describes that hospitalized patients with newly diagnosed cerebrovascular accident (CVA) are considered for endovascular stroke treatment.

250. HCPCS Code G9768

HCPCS G9768 describes that patients used hospice services at any time during the measurement period.

251. HCPCS Code G9769

HCPCS G9769 describes that the patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months.

252. HCPCS Code G9770

HCPCS G9770 describes a peripheral nerve block (PNB), which is a procedure that involves injecting a local anesthetic near a nerve to block pain signals.

253. HCPCS Code G9771

HCPCS G9771 describes that at least one body temperature measurement equal to or greater than 35.5 degrees Celsius (or 95.9 degrees Fahrenheit) was achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time.

254. HCPCS Code G9772

HCPCS G9772 describes the documentation of medical reasons for not achieving at least one body temperature measurement equal to or greater than 35.5 degrees Celsius (or 95.9 degrees Fahrenheit) within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time, such as emergency cases or intentional hypothermia.

255. HCPCS Code G9773

HCPCS G9773 describes that at least one body temperature measurement equal to or greater than 35.5 degrees Celsius (or 95.9 degrees Fahrenheit) was not achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time, and the reason is not given.

256. HCPCS Code G9775

HCPCS G9775 describes that the patient received at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively to prevent nausea and vomiting.

257. HCPCS Code G9776

HCPCS G9776 describes the documentation of medical reasons for not receiving at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively, such as patient intolerance or other medical reasons.

258. HCPCS Code G9777

HCPCS G9777 describes that the patient did not receive at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively to prevent nausea and vomiting.

259. HCPCS Code G9779

HCPCS G9779 describes that patients are breastfeeding at any time during the performance period.

260. HCPCS Code G9780

HCPCS G9780 describes that patients have a diagnosis of rhabdomyolysis at any time during the performance period, which is a condition characterized by the breakdown of muscle tissue.

261. HCPCS Code G9781

HCPCS G9781 describes the documentation of medical reasons for not currently being a statin therapy user or receiving an order (prescription) for statin therapy, such as patients with statin-associated muscle symptoms or allergies to statin medications.

262. HCPCS Code G9782

HCPCS G9782 describes a history of or active diagnosis of familial hypercholesterolemia, which is a genetic disorder characterized by high cholesterol levels.

263. HCPCS Code G9784

HCPCS G9784 describes pathologists/dermatopathologists providing a second opinion on a biopsy, which involves reviewing and confirming the findings of another pathologist or dermatopathologist.

264. HCPCS Code G9785

HCPCS G9785 describes that the pathology report diagnoses cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma and is sent from the pathologist/dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist.

265. HCPCS Code G9786

HCPCS G9786 describes that the pathology report diagnoses cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma and was not sent from the pathologist/dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist.

266. HCPCS Code G9787

HCPCS G9787 describes that the patient is alive as of the last day of the measurement year.

267. HCPCS Code G9788

HCPCS G9788 describes that the most recent blood pressure measurement is less than or equal to 140/90 mm Hg, indicating controlled blood pressure.

268. HCPCS Code G9789

HCPCS G9789 describes blood pressure recorded during inpatient stays, emergency room visits, or urgent care visits.

269. HCPCS Code G9790

HCPCS G9790 describes that the most recent blood pressure measurement is greater than 140/90 mm Hg, or blood pressure is not documented.

270. HCPCS Code G9791

HCPCS G9791 describes that the most recent tobacco status of the patient is tobacco-free.

271. HCPCS Code G9792

HCPCS G9792 describes the most recent tobacco status of the patient is not tobacco-free.

272. HCPCS Code G9793

HCPCS G9793 describes that the patient is currently on a daily aspirin or other antiplatelet medication, which is used to prevent blood clots.

273. HCPCS Code G9794

HCPCS G9794 describes the documentation of medical reasons for not being on a daily aspirin or other antiplatelet medication, such as a history of gastrointestinal bleed or active anticoagulant use.

274. HCPCS Code G9795

HCPCS G9795 describes that the patient is not currently on a daily aspirin or other antiplatelet medication.

275. HCPCS Code G9796

HCPCS G9796 describes that the patient is currently on a statin therapy, which is a medication used to lower cholesterol levels.

276. HCPCS Code G9797

HCPCS G9797 describes that the patient is not on a statin therapy.

277. HCPCS Code G9805

HCPCS G9805 describes that patients used hospice services at any time during the measurement period.

278. HCPCS Code G9806

HCPCS G9806 describes that patients received cervical cytology or an HPV test, which are screening tests for cervical cancer.

279. HCPCS Code G9807

HCPCS G9807 describes that patients did not receive cervical cytology or an HPV test.

280. HCPCS Code G9812

HCPCS G9812 describes that the patient died, including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital but within 30 days of the procedure.

281. HCPCS Code G9813

HCPCS G9813 describes that the patient did not die within 30 days of the procedure or during the index hospitalization.

282. HCPCS Code G9818

HCPCS G9818 describes the documentation of sexual activity, which may be relevant for certain medical conditions or procedures.

283. HCPCS Code G9819

HCPCS G9819 describes that patients used hospice services at any time during the measurement period.

284. HCPCS Code G9820

HCPCS G9820 describes the documentation of a chlamydia screening test with proper follow-up, which is important for the early detection and treatment of chlamydia infections.

285. HCPCS Code G9821

HCPCS G9821 describes the absence of documentation of a chlamydia screening test with proper follow-up.

286. HCPCS Code G9822

HCPCS G9822 describes that patients had an endometrial ablation procedure during the 12 months prior to the index date, which is a minimally invasive procedure to treat abnormal uterine bleeding.

287. HCPCS Code G9823

HCPCS G9823 describes that endometrial sampling or hysteroscopy with biopsy and results were documented during the 12 months prior to the index date of the endometrial ablation.

288. HCPCS Code G9824

HCPCS G9824 describes that endometrial sampling or hysteroscopy with biopsy and results were not documented during the 12 months prior to the index date of the endometrial ablation.

289. HCPCS Code G9830

HCPCS G9830 describes that the patient is HER-2/neu positive, indicating the presence of a specific protein associated with certain types of cancer.

290. HCPCS Code G9831

HCPCS G9831 describes that the patient has AJCC (American Joint Committee on Cancer) Stage at breast cancer diagnosis equal to II or III, indicating the extent of the cancer.

291. HCPCS Code G9832

HCPCS G9832 describes that the patient has AJCC Stage at breast cancer diagnosis equal to I (Ia or Ib) and t-Stage at breast cancer diagnosis does not equal T1, T1a, T1b.

292. HCPCS Code G9838

HCPCS G9838 describes that the patient has metastatic disease at diagnosis.

293. HCPCS Code G9839

HCPCS G9839 describes the use of anti-EGFR monoclonal antibody therapy.

294. HCPCS Code G9840

HCPCS G9840 describes the performance of RAS (KRAS and NRAS) gene mutation testing before initiation of anti-EGFR monoclonal antibody therapy.

295. HCPCS Code G9841

HCPCS G9841 describes the absence of RAS (KRAS and NRAS) gene mutation testing before initiation of anti-EGFR monoclonal antibody therapy.

296. HCPCS Code G9842

HCPCS G9842 describes that the patient has metastatic disease at diagnosis.

297. HCPCS Code G9843

HCPCS G9843 describes the presence of RAS (KRAS and NRAS) gene mutation.

298. HCPCS Code G9844

HCPCS G9844 describes that the patient did not receive anti-EGFR monoclonal antibody therapy.

299. HCPCS Code G9845

HCPCS G9845 describes that the patient received anti-EGFR monoclonal antibody therapy.

300. HCPCS Code G9846

HCPCS G9846 describes patients who died from cancer.

301. HCPCS Code G9847

HCPCS G9847 describes patients who received systemic cancer-directed therapy in the last 14 days of life.

302. HCPCS Code G9848

HCPCS G9848 describes patients who did not receive systemic cancer-directed therapy in the last 14 days of life.

303. HCPCS Code G9858

HCPCS G9858 describes patients enrolled in hospice.

304. HCPCS Code G9859

HCPCS G9859 describes patients who died from cancer.

305. HCPCS Code G9860

HCPCS G9860 describes patients who spent less than three days in hospice care.

306. HCPCS Code G9861

HCPCS G9861 describes patients who spent greater than or equal to three days in hospice care.

307. HCPCS Code G9862

HCPCS G9862 describes the documentation of medical reason(s) for not recommending at least a 10-year follow-up interval.

308. HCPCS Code G9868

HCPCS G9868 describes the receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a Medicare-approved CMMI model, less than 10 minutes.

309. HCPCS Code G9869

HCPCS G9869 describes the receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a Medicare-approved CMMI model, 10-20 minutes.

310. HCPCS Code G9870

HCPCS G9870 describes the receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a Medicare-approved CMMI model, more than 20 minutes.

311. HCPCS Code G9873

HCPCS G9873 describes the attendance of the first Medicare Diabetes Prevention Program (MDPP) core session by an MDPP beneficiary under the MDPP Expanded Model (EM).

312. HCPCS Code G9874

HCPCS G9874 describes the attendance of four total Medicare Diabetes Prevention Program (MDPP) core sessions by an MDPP beneficiary under the MDPP Expanded Model (EM).

313. HCPCS Code G9875

HCPCS G9875 describes the attendance of nine total Medicare Diabetes Prevention Program (MDPP) core sessions by an MDPP beneficiary under the MDPP Expanded Model (EM).

314. HCPCS Code G9876

HCPCS G9876 describes the attendance of two Medicare Diabetes Prevention Program (MDPP) core maintenance sessions by an MDPP beneficiary in months 7-9 under the MDPP Expanded Model (EM).

315. HCPCS Code G9877

HCPCS G9877 describes the attendance of two Medicare Diabetes Prevention Program (MDPP) core maintenance sessions by an MDPP beneficiary in months 10-12 under the MDPP Expanded Model (EM).

316. HCPCS Code G9878

HCPCS G9878 describes the attendance of two Medicare Diabetes Prevention Program (MDPP) core maintenance sessions by an MDPP beneficiary in months 7-9 under the MDPP Expanded Model (EM) with at least 5% weight loss achieved.

317. HCPCS Code G9879

HCPCS G9879 describes the attendance of two Medicare Diabetes Prevention Program (MDPP) core maintenance sessions by an MDPP beneficiary in months 10-12 under the MDPP Expanded Model (EM) with at least 5% weight loss achieved.

318. HCPCS Code G9880

HCPCS G9880 describes a one-time payment available when a Medicare Diabetes Prevention Program (MDPP) beneficiary first achieves at least 5% weight loss from baseline in months 1-12 under the MDPP Expanded Model (EM).

319. HCPCS Code G9881

HCPCS G9881 describes a one-time payment available when a Medicare Diabetes Prevention Program (MDPP) beneficiary first achieves at least 9% weight loss from baseline in months 1-24 under the MDPP Expanded Model (EM).

320. HCPCS Code G9882

HCPCS G9882 describes the attendance of two Medicare Diabetes Prevention Program (MDPP) ongoing maintenance sessions by an MDPP beneficiary in months 13-15 under the MDPP Expanded Model (EM) with at least 5% weight loss maintained.

321. HCPCS Code G9883

HCPCS G9883 describes the attendance of two Medicare Diabetes Prevention Program (MDPP) ongoing maintenance sessions by an MDPP beneficiary in months 16-18 under the MDPP Expanded Model (EM) with at least 5% weight loss maintained.

322. HCPCS Code G9884

HCPCS G9884 describes the attendance of two Medicare Diabetes Prevention Program (MDPP) ongoing maintenance sessions by an MDPP beneficiary in months 19-21 under the MDPP Expanded Model (EM) with at least 5% weight loss maintained.

323. HCPCS Code G9885

HCPCS G9885 describes the attendance of two Medicare Diabetes Prevention Program (MDPP) ongoing maintenance sessions by an MDPP beneficiary in months 22-24 under the MDPP Expanded Model (EM) with at least 5% weight loss maintained.

324. HCPCS Code G9886

HCPCS G9886 describes behavioral counseling for diabetes prevention, in-person, group, 60 minutes.

325. HCPCS Code G9887

HCPCS G9887 describes behavioral counseling for diabetes prevention, distance learning, 60 minutes.

326. HCPCS Code G9888

HCPCS G9888 describes the maintenance of at least 5% weight loss from baseline in months 7-12.

327. HCPCS Code G9890

HCPCS G9890 describes a bridge payment for the first Medicare Diabetes Prevention Program (MDPP) session furnished by an MDPP supplier to an MDPP beneficiary during months 1-24 of the MDPP Expanded Model (EM) who has previously received MDPP services from a different MDPP supplier under the MDPP Expanded Model.

328. HCPCS Code G9891

HCPCS G9891 is a reporting code for a line-item on a claim for a payable MDPP Expanded Model (EM) HCPCS code for a session furnished by the billing supplier under the MDPP Expanded Model and counting toward achievement of the attendance performance goal for the payable MDPP Expanded Model HCPCS code.

329. HCPCS Code G9892

HCPCS G9892 describes the documentation of patient reason(s) for not performing a dilated macular examination.

330. HCPCS Code G9893

HCPCS G9893 describes that a dilated macular exam was not performed, reason not otherwise specified.

331. HCPCS Code G9294

HCPCS G9294 describes a pathology report that includes the pt category and a statement on thickness and ulceration and for PT1, mitotic rate.

332. HCPCS Code G9295

HCPCS G9295 describes a specimen site other than anatomic cutaneous location.

333. HCPCS Code G9296

HCPCS G9296 describes patients with documented shared decision-making including discussion of conservative (non-surgical) therapy prior to the procedure.

334. HCPCS Code G9297

HCPCS G9297 describes shared decision-making including discussion of conservative (non-surgical) therapy prior to the procedure, not documented, reason not given.

335. HCPCS Code G9298

HCPCS G9298 describes patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure.

336. HCPCS Code G9299

HCPCS G9299 describes patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure, reason not given.

337. HCPCS Code G9305

HCPCS G9305 describes that intervention for the presence of a leak of endoluminal contents through an anastomosis is not required.

338. HCPCS Code G9306

HCPCS G9306 describes that intervention for the presence of a leak of endoluminal contents through an anastomosis is required.

339. HCPCS Code G9307

HCPCS G9307 describes no return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure.

340. HCPCS Code G9308

HCPCS G9308 describes an unplanned return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure.

341. HCPCS Code G9309

HCPCS G9309 describes no unplanned hospital readmission within 30 days of the principal procedure.

342. HCPCS Code G9310

HCPCS G9310 describes an unplanned hospital readmission within 30 days of the principal procedure.

343. HCPCS Code G9311

HCPCS G9311 describes no surgical site infection.

344. HCPCS Code G9312

HCPCS G9312 describes a surgical site infection.

345. HCPCS Code G9313

HCPCS G9313 describes that amoxicillin, with or without clavulanate, was not prescribed as the first-line antibiotic at the time of diagnosis for a documented reason.

346. HCPCS Code G9314

HCPCS G9314 describes that amoxicillin, with or without clavulanate, was not prescribed as the first-line antibiotic at the time of diagnosis, reason not given.

347. HCPCS Code G9315

HCPCS G9315 describes that amoxicillin, with or without clavulanate, was prescribed as the first-line antibiotic at the time of diagnosis.

348. HCPCS Code G9316

HCPCS G9316 describes the documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from the risk calculator with the patient or family.

349. HCPCS Code G9317

HCPCS G9317 describes the documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from the risk calculator with the patient or family not completed.

350. HCPCS Code G9318

HCPCS G9318 describes that the imaging study was named according to standardized nomenclature.

351. HCPCS Code G9319

HCPCS G9319 describes that the imaging study was not named according to standardized nomenclature, reason not given.

352. HCPCS Code G9321

HCPCS G9321 describes the count of previous CT and cardiac nuclear medicine studies documented in the 12-month period prior to the current study.

353. HCPCS Code G9322

HCPCS G9322 describes that the count of previous CT and cardiac nuclear medicine studies was not documented in the 12-month period prior to the current study, reason not given.

354. HCPCS Code G9341

HCPCS G9341 describes the search conducted for prior patient CT studies completed at non-affiliated external healthcare facilities or entities within the past 12 months and available through a secure, authorized, media-free, shared archive prior to an imaging study being performed.

355. HCPCS Code G9342

HCPCS G9342 describes that the search was not conducted prior to an imaging study being performed for prior patient CT studies completed at non-affiliated external healthcare facilities or entities within the past 12 months and available through a secure, authorized, media-free, shared archive, reason not given.

356. HCPCS Code G9344

HCPCS G9344 describes that due to system reasons, the search was not conducted for DICOM format images for prior patient CT imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive.

357. HCPCS Code G9345

HCPCS G9345 describes the follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules based on nodule size and patient risk factors.

358. HCPCS Code G9347

HCPCS G9347 describes that the follow-up recommendations were not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given.

359. HCPCS Code G9351

HCPCS G9351 describes that more than one CT scan of the paranasal sinuses was ordered or received within 90 days after diagnosis.

360. HCPCS Code G9352

HCPCS G9352 describes that more than one CT scan of the paranasal sinuses was ordered or received within 90 days after the date of diagnosis, reason not given.

361. HCPCS Code G9353

HCPCS G9353 describes that more than one CT scan of the paranasal sinuses was ordered or received within 90 days after the date of diagnosis for documented reasons.

362. HCPCS Code G9354

HCPCS G9354 describes that one CT scan or no CT scan of the paranasal sinuses was ordered within 90 days after the date of diagnosis.

363. HCPCS Code G9355

HCPCS G9355 describes that elective delivery (without medical indication) by cesarean birth or induction of labor was not performed (<39 weeks of gestation).

364. HCPCS Code G9356

HCPCS G9356 describes that elective delivery (without medical indication) by cesarean birth or induction of labor was performed (<39 weeks of gestation).

365. HCPCS Code G9357

HCPCS G9357 describes that post-partum screenings, evaluations, and education were performed.

366. HCPCS Code G9358

HCPCS G9358 describes that post-partum screenings, evaluations, and education were not performed.

367. HCPCS Code G9361

HCPCS G9361 describes the medical indication for delivery by cesarean birth or induction of labor (<39 weeks of gestation) with documentation of reason(s) for elective delivery.

368. HCPCS Code G9364

HCPCS G9364 describes sinusitis caused by, or presumed to be caused by, bacterial infection.

369. HCPCS Code G9367

HCPCS G9367 describes at least two orders for high-risk medications from the same drug class.

370. HCPCS Code G9368

HCPCS G9368 describes at least two orders for high-risk medications from the same drug class not ordered.

371. HCPCS Code G9380

HCPCS G9380 describes that the patient was offered assistance with end-of-life issues or the existing end-of-life plan was reviewed or updated during the measurement period.

372. HCPCS Code G9382

HCPCS G9382 describes that the patient was not offered assistance with end-of-life issues or the existing end-of-life plan was not reviewed or updated during the measurement period.

373. HCPCS Code G9383

HCPCS G9383 describes that the patient received screening for HCV infection within the 12-month reporting period.

374. HCPCS Code G9384

HCPCS G9384 describes the documentation of medical reason(s) for not receiving annual screening for HCV infection.

375. HCPCS Code G9385

HCPCS G9385 describes the documentation of patient reason(s) for not receiving annual screening for HCV infection.

376. HCPCS Code G9386

HCPCS G9386 describes that screening for HCV infection was not received within the 12-month reporting period, reason not given.

377. HCPCS Code G9393

HCPCS G9393 describes a patient with an initial PHQ-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) PHQ-9 score of less than five.

378. HCPCS Code G9394

HCPCS G9394 describes a patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident, or receiving hospice or palliative care any time during the measurement or assessment period.

379. HCPCS Code G9395

HCPCS G9395 describes a patient with an initial PHQ-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) PHQ-9 score greater than or equal to five.

380. HCPCS Code G9396

HCPCS G9396 describes a patient with an initial PHQ-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days).

381. HCPCS Code G9402

HCPCS G9402 describes that the patient received follow-up within 30 days after discharge.

382. HCPCS Code G9403

HCPCS G9403 describes that the clinician documented a reason the patient was not able to complete a 30-day follow-up from acute inpatient setting discharge.

383. HCPCS Code G9404

HCPCS G9404 describes that the patient did not receive follow-up within 30 days after discharge.

384. HCPCS Code G9405

HCPCS G9405 describes that the patient received follow-up within 7 days after discharge.

385. HCPCS Code G9406

HCPCS G9406 describes that the clinician documented a reason the patient was not able to complete a 7-day follow-up from acute inpatient setting discharge.

386. HCPCS Code G9407

HCPCS G9407 describes that the patient did not receive follow-up within 7 days after discharge.

387. HCPCS Code G9408

HCPCS G9408 describes patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days.

388. HCPCS Code G9409

HCPCS G9409 describes patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days.

389. HCPCS Code G9410

HCPCS G9410 describes a patient admitted within 180 days, status post CIED implantation, replacement, or revision with an infection requiring device removal or surgical revision.

390. HCPCS Code G9411

HCPCS G9411 describes a patient not admitted within 180 days, status post CIED implantation, replacement, or revision with an infection requiring device removal or surgical revision.